Today's pre-market stock movers: TCOM, OXY, SAVE, GS and more

• $Kezar Life Sciences (KZR.US)$ +92% (announces positive top line results from the MISSION Phase 2 trial)

• $Sutro Biopharma (STRO.US)$ +24.5% (Sutro Biopharma and Astellas to collaborate to advance novel immunostimulatory antibody-drug conjugates)

• $Ceragon (CRNT.US)$ +17.7% (AVNW to acquire all shares of CRNT that it does not already own for $2.80/sh)

• $Trip.com (TCOM.US)$ +15.6% (In reaction to earnings/guidance)

• $Apyx Medical (APYX.US)$ +8% (announced the receipt of 510(k) clearance for the use of the Renuvion Dermal handpiece for specific dermatological procedures for the treatment of moderate to severe wrinkles and rhytides limited to patients with Fitzpatrick skin typesIIIor III)

• $Velodyne Lidar (VLDR.US)$ +7.1% (announced a multi-year agreement for its lidar sensors with Boston Dynamics)

• $Vonage (VG.US)$ +6.4% (Ericsson (ERIC) provides update on its acquisition of Vonage)

• $Roivant Sciences (ROIV.US)$ +6.4% (Roivant Sciences and Pfizer (PFE) unveil Priovant Therapeutics and ongoing registrational studies for oral brepocitinib; also reported earnings)

• $Eiger BioPharmaceuticals (EIGR.US)$ +5% (announces results from multiple presentations)

• $IDEAYA Biosciences (IDYA.US)$ +5% (reports development candidate nomination of a potential first-in-class PolTheta Helicase inhibitor in collaboration with GSK)

• $Invesco Mortgage Capital Inc (IVR.US)$ +4.9% (reduces leverage and rotates Agency RMBS portfolio into higher coupons)

• $Playtika Holding (PLTK.US)$ +4.9% (Joffre Capital aiming to purchase majority stakein PLTK accordingto Axios)

• $Spirit Airlines (SAVE.US)$ +4.1% (JBLU increases offer to acquireSAVE; TIG Advisors send letter to SAVE Board regarding its intention to vote "against" proposed merger with Frontier Group Holdings)

• $Occidental Petroleum (OXY.US)$ +4% (10% owner Berkshire Hathaway (Warren Buffett) disclosed the purchase of ~794K shares worth ~$44mln(transaction date 6/23))

• $R1 RCM (Delisted) (RCM.US)$ +3.3% (In reaction to earnings/guidance)

• $TD Synnex (SNX.US)$ +1.6% (In reaction to earnings/guidance)

• $Frontier Group (ULCC.US)$ +3%(JBLUincreases offer to acquire SAVE)

• $ESSA Pharma (EPIX.US)$ +3% (presents clinical updateonEPI-7386)

• $Morgan Stanley (MS.US)$ +2.9% (discusses stress test results to increase dividend and announces $20bln share buyback plan)

• $The Lovesac (LOVE.US)$ +2.6% (Lovesac and Joybird resolve patent litigation)

• $Northern Lights Acquisition Corp (NLIT.US)$ +2.6% (reschedules Special Meeting to approve acquisition)

• $Truist Financial (TFC.US)$ +2.5% (discusses stress test results to increase dividend by 8%)

• $Griffon (GFF.US)$ +2.4% (declares special cash dividend of $2/sh)

• $Earthstone Energy (ESTE.US)$ +2.2% (announces northern Delaware basin asset acquisition for ~$627million)

• $Aviat Networks (AVNW.US)$ +1.9% (AVNW to acquire all shares of CRNT that it does not already own for $2.80/sh)

• $Guess (GES.US)$ +1.8% (completes previously disclosed $175mln ASR program)

• $Goldman Sachs (GS.US)$ +1.8% (discusses stress test results to increase dividend by 25%)

• $Citizens Financial (CFG.US)$ +1.3% (discusses stress test results increases share repurchase authorization to $1bln; willconsider dividend increase)

• $Capital One Financial (COF.US)$ +1.3%(discusses stress test results SCB is 3.1%)

• $Citigroup (C.US)$ +1.3% (discusses stress test results intends to maintain current dividend)

• $Schrodinger (SDGR.US)$ +1.3% (FDA cleared its investigational new drug application for its MALT1 inhibitor SGR-1505)

• $Bank of America (BAC.US)$ +1.2% (discusses stress test results to increase dividend by 5%)

• $JPMorgan (JPM.US)$ +1.2% (discusses stress test results intends to maintain current dividend)

• $Hewlett Packard Enterprise (HPE.US)$ +1.2%(announcesa new partnerprogram)

• $Blink Charging (BLNK.US)$ +1.2% (Trilantic Capital Partners discloses 5.7% passive stake)

• $Wells Fargo & Co (WFC.US)$ +1% (discusses stress test resultstoincrease dividend by 20%)

• $Fifth Third Bancorp (FITB.US)$ +1% (discusses stress test results to recommend to board to increase dividend)

• $Lands'End (LE.US)$ +1% (announces $50million share repurchase authorization)

• $Fortinet (FTNT.US)$ +2.8% (upgraded to Outperform from Market Perform at BMO Capital Markets)

• $Cognyte Software (CGNT.US)$ -22.4% (In reaction to earnings/guidance)

• $Concentrix (CNXC.US)$ -5.1% (In reaction to earnings/guidance)

• $Jazz Pharmaceuticals (JAZZ.US)$ -3.8% (Top-line Results from Phase 3 Trial Evaluating Nabiximols Oromucosal Spray)

• $Robinhood (HOOD.US)$ -3.4% (FTX CEO says co not having any active M&A conversations with HOOD according to MarketWatch)

• $Jefferies Financial (JEF.US)$ -2.6% (also authorizes new $250 mln share repurchase program), NKE-1.9% (also authorizes new $18 bln share repurchase program)

• $TAL Education (TAL.US)$ -1.9% (Provides Update on Status under Holding Foreign Companies Accountable Act)

• $La-Z-Boy (LZB.US)$ -0.9% (Lovesac and Joybird resolve patent litigation)

• $State Street (STT.US)$ -0.8% (discusses stress test results to increase dividend by 10% to begin its existing share repurchase program in Q4)

• $Royal Philips (PHG.US)$ -0.7% (provides update on Philips Respironics' PE-PUR sound abatement foam test and research program)

• $Farfetch (FTCH.US)$ -2.6% (downgraded to Neutral from Buy at UBS)

• $eBay (EBAY.US)$ -2.4% (downgraded to Neutral from Buy at UBS)

• $Epizyme (EPZM.US)$ -1.4% (downgraded to Market Perform from Outperform at Cowen)